Limbix

Limbix is a prescription digital therapeutics company focused on adolescent mental health. Founded in 2016 and headquartered in Palo Alto, California, it developed SparkRx — a cognitive behavioral therapy (CBT)-based digital therapeutic program for teens and young adults experiencing symptoms of depression. Limbix pairs clinical expertise with technology, employing clinicians, product designers, researchers, and engineers focused on delivering accessible mental health treatment to young people. The company raised $31 million in a Series A and was acquired by Big Health in July 2023.